Silencing MCT4, a lactate transporter, inhibited H3K18la and motility in TROP2‐overexpressing CRC cells consistent with glycolytic inhibitors (Figures S5B and C and S5E and F). Here, TACSTD2 is linked to colorectal carcinoma.